CNBC · General

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

· By Angelica Peebles, Annika Kim Constantino
Story summary

The U.S. Food and Drug Administration approved Eli Lilly's GLP-1 pill, the company said, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight-loss medications.

Read at CNBC

Opens the original publisher in a new tab. Full articles belong to their publishers; a subscription may be required.

Your local edition.

Choose a timezone for story timestamps and date filters.